AURA BIOSCIENCES INC. overview
AURA BIOSCIENCES INC.
> News
GlobeNewsWire published a news.
Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting
•
•
GlobeNewsWire •
Stocks •
More AURA BIOSCIENCES INC. news...
Thank you
Chart
Statistics
- Analyses : 0
- Followers : 0